These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1339 related articles for article (PubMed ID: 34351057)

  • 41. Late-Onset Vaccine-Induced Immune Thombotic Thrombocytopenia (VITT) with Cerebral Venous Sinus Thrombosis.
    Saleh M; Zimmermann J; Lehnen NC; Pötzsch B; Weller JM
    J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106311. PubMed ID: 35093626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination.
    Patterson WM; Greene BD; Tefera L; Bena J; Milinovich A; Mehta N; Chung MK; Kapadia S; Svensson LG; Cameron SJ
    J Thromb Thrombolysis; 2023 Apr; 55(3):426-431. PubMed ID: 36653575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
    van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
    Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis.
    Dorgalaleh A; Shabannezhad A; Hassani S
    Ann Hematol; 2023 Nov; ():. PubMed ID: 38030893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating
    Konstantinou GN
    Hum Vaccin Immunother; 2022 Nov; 18(5):2050654. PubMed ID: 35412949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2.
    Pang X; Liu H; He X; Ji T; Zhu Y; Cui Y
    Front Immunol; 2021; 12():782335. PubMed ID: 35095856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions.
    Marchandot B; Curtiaud A; Trimaille A; Sattler L; Grunebaum L; Morel O
    Eur Heart J Open; 2021 Sep; 1(2):oeab014. PubMed ID: 35915769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions.
    Thakur KT; Tamborska A; Wood GK; McNeill E; Roh D; Akpan IJ; Miller EC; Bautista A; Claassen J; Kim CY; Guekht A; Pardo CA; Williams O; García-Azorín D; Prasad K; Schmutzhard E; Michael BD; Chou SH; Winkler AS; Solomon T; Elkind MS
    J Neurol Sci; 2021 Aug; 427():117532. PubMed ID: 34134058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report.
    Di Pietro M; Dono F; Consoli S; Evangelista G; Pozzilli V; Calisi D; Barbone F; Bonanni L; Onofrj M; De Angelis MV; Sensi SL
    Neurol Sci; 2022 May; 43(5):2951-2956. PubMed ID: 35217969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination.
    Curcio R; Gandolfo V; Alcidi R; Giacomino L; Campanella T; Casarola G; Rossi R; Chiatti L; D'Abbondanza M; Commissari R; Gresele P; Pucci G; Vaudo G
    Int J Infect Dis; 2022 Mar; 116():154-156. PubMed ID: 34986404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of a severe bilateral pulmonary embolism as a complication of VITT following vaccination with AstraZeneca COVID-19 vaccine.
    Elkoumy M; Schoen J; Loew A
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35545306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE).
    Major A; Carll T; Chan CW; Christenson C; Aldarweesh F; Wool GD; Cohen KS
    J Clin Apher; 2022 Feb; 37(1):117-121. PubMed ID: 34672380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.
    Clarke L; Brighton T; Chunilal SD; Lee CSM; Passam F; Curnow J; Chen VM; Tran HA
    Vaccine; 2023 May; 41(20):3285-3291. PubMed ID: 37085453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.
    Tsilingiris D; Vallianou NG; Karampela I; Dalamaga M
    Metabol Open; 2021 Sep; 11():100101. PubMed ID: 34179744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia].
    Hvas AM; Ostrowski SR; Frederiksen H; Kampmann P; Stensballe J
    Ugeskr Laeger; 2021 Jul; 183(29):. PubMed ID: 34356021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
    van der Neut Kolfschoten M; Inganäs H; Perez-Peinado C; Calado da Silva Freire J; Melchers JM; van Dijk N; Przeradzka M; Kourkouta E; van Manen D; Vellinga J; Custers J; Bos R
    J Thromb Haemost; 2024 Apr; 22(4):1046-1055. PubMed ID: 38159648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?
    Lundstrom K; Barh D; Uhal BD; Takayama K; Aljabali AAA; Abd El-Aziz TM; Lal A; Redwan EM; Adadi P; Chauhan G; Sherchan SP; Azad GK; Rezaei N; Serrano-Aroca Á; Bazan NG; Hassan SS; Panda PK; Pal Choudhury P; Pizzol D; Kandimalla R; Baetas-da-Cruz W; Mishra YK; Palu G; Brufsky AM; Tambuwala MM; Uversky VN
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
    Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
    J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study.
    Schultz NH; Søraas AVL; Sørvoll IH; Akkök ÇA; Vetlesen A; Bhamra JS; Ahlen MT; Holme PA; Aamodt AH; Skagen K; Skattør TH; Skjelland M; Wiedmann MK
    J Stroke Cerebrovasc Dis; 2023 Jan; 32(1):106860. PubMed ID: 36403363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.